5 assets in Mucopolysaccharidosis Type 1

Therapeutic assets addressing Mucopolysaccharidosis Type 1, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Mucopolysaccharidosis Type 1	University of California, San Francisco	P4	BBB (72)
Adalimumab Mucopolysaccharidosis Type 1	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	P1/2	CCC (52)
Devafidugene Civaparvovec Mucopolysaccharidosis Type 1	Sangamo Therapeutics	P1/2	CCC (48)